We generated ApoE/CD6 DKO mice to address the role of CD6 in cardiovascular disease given the recent focus of CD6 as a therapeutic target for the treatment of several autoimmune diseases [16, 19, 22–25]. The gene discussed is CD6; the disease is cardiovascular disorder.